More than 90% of cancer mortalities are due to cancer that has metastasized. Therefore, it is crucial to intensify research on metastasis formation and therapy. Here, we describe for the first time the metastasizing ability of the human cervical cancer cell line C33A in athymic nude mice after subcutaneous implantation of tumor cells. In this model, we demonstrated a steady progression of lumbar and renal lymph node metastases during tumor development. Besides predominantly occurring lymphatic metastases, we visualized the formation of hematogenous metastases utilizing red fluorescent protein (RFP) expressing C33A-RFP cells. RFP positive cancer cells were found migrating in blood vessels and forming micrometastases in lungs of tumor-bearing mice. Next, we set out to analyze the influence of oncolytic virotherapy in the C33A-RFP model and demonstrated an efficient virus-mediated reduction of tumor size and metastatic burden. These results suggest the C33A-RFP cervical cancer model as a new platform to analyze cancer metastases as well as to test novel treatment options to combat metastases.
References
[1]
Talmadge JE, Fidler IJ (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649–5669. doi: 10.1158/0008-5472.can-10-1040
[2]
Sugarbaker PH (1981) Carcinoma of the colon—prognosis and operative choice. Curr Probl Surg 18: 753–802.
[3]
Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, et al. (2007) Patterns of metastasis in human solid cancers. Cancer Treat Res 135: 209–221. doi: 10.1007/978-0-387-69219-7_16
[4]
Khanna C, Hunter K (2005) Modeling metastasis in vivo. Carcinogenesis 26: 513–523. doi: 10.1093/carcin/bgh261
[5]
Pearson HB, Pouliot N (2012) Modeling Metastasis In Vivo.
[6]
Jenkins DE, Yu SF, Hornig YS, Purchio T, Contag PR (2003) In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 20: 745–756. doi: 10.1023/b:clin.0000006817.25962.87
[7]
Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, et al. (1998) Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model. Clin Cancer Res 4: 2009–2014.
[8]
Bastide C, Bagnis C, Mannoni P, Hassoun J, Bladou F (2002) A Nod Scid mouse model to study human prostate cancer. Prostate Cancer Prostatic Dis 5: 311–315. doi: 10.1038/sj.pcan.4500606
[9]
Gu J, Zhao J, Li Z, Yang Z, Zhang J, et al. (2003) Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum 46: 1659–1666. doi: 10.1007/bf02660772
[10]
Tsutsumi S, Kuwano H, Morinaga N, Shimura T, Asao T (2001) Animal model of para-aortic lymph node metastasis. Cancer Lett 169: 77–85. doi: 10.1016/s0304-3835(00)00622-4
[11]
Chen J, Stavro PM, Thompson LU (2002) Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 43: 187–192. doi: 10.1207/s15327914nc432_9
[12]
Li X, Wang J, An Z, Yang M, Baranov E, et al. (2002) Optically imageable metastatic model of human breast cancer. Clin Exp Metastasis 19: 347–350.
[13]
Yamaguchi K, Ura H, Yasoshima T, Shishido T, Denno R, et al. (2000) Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes. J Exp Clin Cancer Res 19: 113–120.
[14]
Fujihara T, Sawada T, Hirakawa K, Chung YS, Yashiro M, et al. (1998) Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis 16: 389–398.
[15]
An Z, Jiang P, Wang X, Moossa AR, Hoffman RM (1999) Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis 17: 265–270.
[16]
Cairns RA, Hill RP (2004) A fluorescent orthotopic model of metastatic cervical carcinoma. Clin Exp Metastasis 21: 275–281. doi: 10.1023/b:clin.0000037729.75981.9e
[17]
Duan P, Duan G, Liu YJ, Zheng BB, Hua Y, et al. (2012) Establishment of a visualized nude mouse model of cervical carcinoma with high potential of lymph node metastasis via total orthotopic transplantation. Eur J Gynaecol Oncol 33: 472–476.
[18]
Cairns RA, Hill RP (2004) Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 64: 2054–2061. doi: 10.1158/0008-5472.can-03-3196
[19]
Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE (2007) Oncolytic viruses in cancer therapy. Cancer Lett 254: 178–216. doi: 10.1016/j.canlet.2007.02.002
[20]
Zhang Q, Liang C, Yu YA, Chen N, Dandekar T, et al. (2009) The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation. Mol Genet Genomics 282: 417–435. doi: 10.1007/s00438-009-0475-1
[21]
Zhang Q, Yu YA, Wang E, Chen N, Danner RL, et al. (2007) Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res 67: 10038–10046. doi: 10.1158/0008-5472.can-07-0146
[22]
Gentschev I, Donat U, Hofmann E, Weibel S, Adelfinger M, et al. (2010) Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. J Biomed Biotechnol 2010: 489759. doi: 10.1155/2010/489759
[23]
Yu YA, Galanis C, Woo Y, Chen N, Zhang Q, et al. (2009) Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Mol Cancer Ther 8: 141–151. doi: 10.1158/1535-7163.mct-08-0533
[24]
Stubenrauch F, Straub E, Fertey J, Iftner T (2007) The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins. Int J Cancer 121: 2284–2292. doi: 10.1002/ijc.22907
[25]
Weibel S, Raab V, Yu YA, Worschech A, Wang E, et al. (2011) Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. BMC Cancer 11: 68. doi: 10.1186/1471-2407-11-68
[26]
Weibel S, Stritzker J, Eck M, Goebel W, Szalay AA (2008) Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 10: 1235–1248. doi: 10.1111/j.1462-5822.2008.01122.x
[27]
Donat U, Weibel S, Hess M, Stritzker J, Hartl B, et al. (2012) Preferential Colonization of Metastases by Oncolytic Vaccinia Virus Strain GLV-1h68 in a Human PC-3 Prostate Cancer Model in Nude Mice. PLoS One 7: e45942. doi: 10.1371/journal.pone.0045942
[28]
Mountain CF, Dresler CM (1997) Regional lymph node classification for lung cancer staging. Chest 111: 1718–1723. doi: 10.1378/chest.111.6.1718
[29]
Smith JA Jr, Whitmore WF Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126: 591–593.
[30]
Crede RH, Benjamin JE, et al. (1949) Primary carcinoma of the liver (cholangioma) with regional lymph node and bilateral ovarian metastases. Cinci J Med 30: 139–144.
[31]
Langley RR, Fidler IJ (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297–321. doi: 10.1210/er.2006-0027
[32]
Karkkainen MJ, Makinen T, Alitalo K (2002) Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol 4: E2–5. doi: 10.1038/ncb0102-e2
[33]
Sleeman JP (2000) The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157: 55–81. doi: 10.1007/978-3-642-57151-0_6
[34]
Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9 Suppl 54–9. doi: 10.1634/theoncologist.9-90005-4
[35]
Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Hogerle S, et al. (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218: 776–782. doi: 10.1148/radiology.218.3.r01mr19776
[36]
Unno Y, Shino Y, Kondo F, Igarashi N, Wang G, et al. (2005) Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain. Clin Cancer Res 11: 4553–4560. doi: 10.1158/1078-0432.ccr-04-2610
[37]
Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, et al. (2006) Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 98: 1482–1493. doi: 10.1093/jnci/djj397
[38]
Kelly KJ, Woo Y, Brader P, Yu Z, Riedl C, et al. (2008) Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Hum Gene Ther 19: 774–782. doi: 10.1089/hum.2008.036
[39]
Lin SF, Price DL, Chen CH, Brader P, Li S, et al. (2008) Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo. J Clin Endocrinol Metab 93: 4403–4407. doi: 10.1210/jc.2008-0316
